GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Mon, 22 Apr 2024

Trading levels for ONCE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 113.57 .
R2 113.57 .
R1 113.57 .
Current price: 113.57
Support S1 113.57 .
S2 113.57 .
S3 113.57 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 113.57
Support S1 109.99 -3.15%
S2 109.00 -4.02%
S3 108.99 -4.03%

ONCE Predictions History

4 years ago
NameNotImportant predicted that ONCE for 2019-05-03 is going $109.35 (1.22%)

4 years ago
NameNotImportant predicted that ONCE for 2019-04-29 is going $105.62 (-2.09%)

4 years ago
NameNotImportant predicted that ONCE for 2019-04-22 is going $112.14 (1.37%)

5 years ago
JS predicted that ONCE for 2019-02-19 is going $52.16 (2.09%)

6 years ago
JS predicted that ONCE for 2017-09-25 is going $83.90 (-3.55%)

6 years ago
Khoi.Le.12196 predicted that ONCE for 2017-09-25 is going $90.00 (5.70%)

Rank:
Click to get the best stock tips daily for free!

About Spark Therapeutics

Spark Therapeutics Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company develops SPK-RPE65, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia... ONCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT